Key facts
Is there a blanket rule
No. Decisions are made case by case
Who decides
You, with a Consultant Psychiatrist and your maternity team
Main UK information source
UKTIS, and its patient service BUMPS
Should you stop suddenly
No. Speak to your prescriber first
When to raise it
Before conceiving if possible, or as soon as you know
Untreated ADHD
Carries its own risks, which form part of the balance
The honest position
This is one of the few areas in ADHD treatment where a general guide cannot give you the answer. The evidence base for ADHD medicines in pregnancy is smaller than for many other medicines, and the right decision depends heavily on individual circumstances.
What we can do is explain how the decision is approached, what the UK information sources are, and what to raise and when. The decision itself belongs with you, a Consultant Psychiatrist, and your maternity team.
Do not stop suddenly
If you are taking ADHD medication and discover you are pregnant, do not stop without speaking to your prescriber. Stopping abruptly has its own consequences, and guanfacine in particular is reduced gradually. Contact your prescriber promptly instead.
How the decision is weighed
The question is never simply whether a medicine carries risk. It is whether continuing carries more risk than stopping, for you specifically.
Untreated ADHD is not neutral in pregnancy. Depending on the person it can affect the ability to attend appointments, follow medical advice, manage other conditions, drive safely, hold down work, and maintain mental health. Where those risks are substantial, they weigh in the balance alongside the medicine.
Against that sits the evidence about the medicine itself, which varies by drug and is generally less complete than anyone would like. A specialist will look at what is known, at the stage of pregnancy, and at how much difficulty stopping would cause you.
Clinical context
Some people continue, some pause, some switch
All three are legitimate outcomes. Some people stop before conceiving and manage with non-medication strategies. Some continue at the lowest effective dose because stopping would carry greater risk. Some switch to a different medicine.
What matters is that the decision is made deliberately, with a specialist and your maternity team, rather than by default or in panic after a positive test.
Where to get reliable UK information
There is a dedicated UK service for exactly this question, and it is more useful than general searching.
UKTIS and BUMPS
The UK Teratology Information Service produces the evidence summaries used by UK clinicians on medicines in pregnancy. Its patient-facing service, BUMPS, publishes the same information written for the public, medicine by medicine.
BUMPS is the single most useful starting point if you want to read something before your appointment. It is written for patients, it is UK-specific, and it is kept current, which is more than can be said for most of what a search returns.
Your clinical team
Your Consultant Psychiatrist, GP, midwife and obstetric team should all know what you are taking. If you are under more than one team, do not assume they have spoken to each other.
What to plan for if you do stop
If the decision is to stop, it is worth planning for what stopping actually means rather than treating it as simply an absence. The difficulties medication was managing do not pause because you are pregnant, and the months ahead involve more appointments, more information to retain and more decisions than usual.
- Put appointments in a shared calendar with reminders, not on paper
- Ask for written summaries after appointments rather than relying on recall
- Bring someone to appointments where you can, as a second memory
- Tell your midwife you have ADHD, so information can be given in a usable form
- Consider coaching or therapy for the period you are off medication
- Agree in advance when treatment would restart after delivery
That last point matters. Deciding after the birth, while sleep-deprived and adjusting to a newborn, is much harder than agreeing a plan while pregnant. Your Consultant Psychiatrist can set out what restarting would involve and whether titration would need repeating.
Non-medication support is not a lesser option here. Adjustments at work, structure at home and coaching or therapy do real work, and they are unaffected by pregnancy or breastfeeding.
Breastfeeding
Breastfeeding is a separate decision from pregnancy and is weighed separately. Medicines differ in how much passes into breast milk, and the practical considerations are different again.
As with pregnancy, the balance includes the benefits of breastfeeding, the effect of untreated ADHD on your ability to care for a newborn, and what is known about the specific medicine. Sleep deprivation in the postnatal period affects everyone, and it can make unmanaged ADHD considerably harder.
Speak to your prescriber before delivery rather than after, so a plan is in place. BUMPS and UKTIS cover breastfeeding as well as pregnancy for individual medicines.
If you are planning a pregnancy
Raising it before conceiving is much easier than raising it afterwards, because it allows a planned approach rather than a reactive one.
- Tell your Consultant Psychiatrist you are planning a pregnancy
- Ask what the options are for your specific medicine
- Ask what would happen if you stopped, and how you would manage
- Read the BUMPS page for your medicine before the appointment
- Make sure your GP and, later, your midwife know what you take
- Agree a plan for what happens if you conceive sooner than expected
If you become pregnant unexpectedly while taking ADHD medication, contact your prescriber promptly. Do not stop first and ask afterwards.
- Non-stimulant medication Atomoxetine, guanfacine and clonidine
- ADHD treatment options Coaching, therapy and support alongside medication
- Side effects in full What to watch for, and when to seek help
Common questions
Can I take ADHD medication while pregnant?
There is no blanket rule. Some people continue, some pause and some switch. The decision is made individually with a Consultant Psychiatrist and your maternity team, weighing the risks of untreated ADHD alongside what is known about the medicine.
Should I stop my ADHD medication if I find out I am pregnant?
Do not stop without speaking to your prescriber. Contact them promptly instead. Stopping abruptly has its own consequences, and guanfacine in particular is reduced gradually.
Where can I find UK information on my specific medicine?
BUMPS, the patient service of the UK Teratology Information Service, publishes summaries medicine by medicine. It is UK-specific, written for patients and kept current.
Can I breastfeed while taking ADHD medication?
It is a separate decision from pregnancy and is weighed separately. Medicines differ in how much passes into breast milk. Speak to your prescriber before delivery so a plan is in place.
Is untreated ADHD a risk in pregnancy?
It can be, depending on the person. It may affect attending appointments, following medical advice, managing other conditions, driving safely and maintaining mental health. Those risks form part of the balance.
Who should know what I am taking?
Your Consultant Psychiatrist, GP, midwife and obstetric team. If you are under more than one team, do not assume they have spoken to each other.
Important
This information is general and educational. It is not a substitute for medical advice. Decisions about starting, changing or stopping ADHD medication are always made together with a Consultant Psychiatrist following a full assessment.
Considering an ADHD assessment?
Any conversation about medication starts with a diagnosis. Our GMC-registered Consultant Psychiatrists assess adults and children. Assessments are £695 online and £1,095 in person in London or Manchester.
No GP referral needed. Appointments are usually available within weeks.
References
- Best Use of Medicines in Pregnancy (BUMPS) UK Teratology Information Service
- UK Teratology Information Service UKTIS
- Attention deficit hyperactivity disorder: diagnosis and management (NG87) National Institute for Health and Care Excellence
- Attention deficit hyperactivity disorder treatment summary British National Formulary
Last reviewed September 2026. Next review due September 2027.





